SCHEMBL7970039

SCHEMBL7970039

CC(C)(C)OC(=O)N1CCC(C(=O)N2CCc3ccc4[nH]c(=O)c(=O)[nH]c4c3C2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
RECQL P46063 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ESR2 Q92731 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
NR1H2 P55055 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
STS P08842 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983577 0.80 GRIA1 (0.54) HPGDRECQLKDM4EMAPTTHRB
SCHEMBL9092377 0.80 EPHX2 (0.48) NPC1RAB9APTPN2PTPN1PTPN6
SCHEMBL29256775 0.71 HPGD (0.71) HPGDRECQLNPC1RAB9APTPN2
SCHEMBL1626801 0.71 HPGD (0.53) HPGDRECQLNPC1RAB9AESR2
SCHEMBL26130562 0.71 HPGD (0.62) HPGDRECQLNPC1RAB9APTPN2
SCHEMBL30895649 0.71 HPGD (0.62) HPGDRECQLNPC1RAB9APTPN2
SCHEMBL31531057 0.70 ESR2 (0.50) ESR2NR1H2PRMT5WDR77KDM4E
SCHEMBL974703 0.69 GPR119 (0.55) HPGDRECQLNPC1RAB9AESR2
SCHEMBL6098788 0.67 ESR2 (0.48) NPC1RAB9AESR2NR1H2PRMT5
SCHEMBL1867980 0.67 HPGD (0.50) HPGDRECQLPTPN2PTPN1PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996028445-A1 NOVEL GLUTAMATE (AMPA/KAINATE) RECEPTOR ANTAGONISTS: N-SUBSTITUTED FUSED AZACYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-09-19 WO claimed
US-6197771-B1 NERVOUS SYSTEM DISORDERS; ANTIISCHEMIC AGENTS; ALZHEIMER'SDISEASE; PARKINSON'S DISEASE; HUNTINGTON'S DISEASE WARNER-LAMBERT COMPANY 2001-03-06 US disclosed
US-6057313-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-05-02 US disclosed
WO-1996028445-A1 NOVEL GLUTAMATE (AMPA/KAINATE) RECEPTOR ANTAGONISTS: N-SUBSTITUTED FUSED AZACYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-09-19 WO disclosed